Patent applications published 4 May 2011
Selected patent applications from the weekly European Patents Bulletin
- Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor
Janssen Pharmaceutica 2315521*
- Pharmaceutical formulations and methods for treating respiratory tract infections
Plumatrix 2315580*
- Topical compsn for the treatment of actinic keratosis
Almirall Hermal 2315581*
- Probiotic compsn useful for dietary augmentation and/or combating disease states and adverse physiological conditions
Cobb, Mark 2315582*
- Formulation for improving the bioavailability of a hydrophobic molecule
Yvery 2315583*
- Microencapsulate and process for the manufacture thereof
Feyecon; Friesland Brands 2315584*
- Controlled release treatment of depression
E-Therapeutics 2315585*
- 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
Merz Pharma 2315586*
- Therapeutic compsns containing macitentan
Actelion Pharmaceuticals 2315587*
- 6-1H-imidazo-quinoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands
Rottapharm 2315588*
- Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoreceptor agonist
AstraZeneca; Pulmagen Therapeutics (Synergy) 2315589*
- Pyrrole inhibitors of S-nitrosoglutathione reductase
N30 Pharmaceuticals 2315590*
- Novel pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
N30 Pharmaceuticals 2315591*
- Treatment of pulmonary arterial hypertension
Novartis 2315592*
- Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
Sanofi-Aventis 2315593*
- Methods of treating a meiotic kinesin-associated disease
Dana-Farber Cancer Institute 2315594*
- Probiotics to increase IGA secretion in infants born by caesarian section
Nestec 2315595*
- Process for extraction of glucosinolates from broccoli seeds
DSM IP Assets 2315596*
- Novel compsns and methods
GlaxoSmithKline Biologicals; Glaxo Group 2315597*
- Compsns of activated botulinum toxin type B
Solstice Neurosciences 2315598*
- Pharmaceutical compsns comprising antibodies binding to EBV (Epstein-Barr virus) protein BARF1
Centre National de la Recherche Scientifique (CNRS); University Claude Bernard Lyon 2315599*
- Compsns and methods related to SIRT1 function
The Regents of the University of California 2315600*
- Combination of a C-met antagonist and an aminoheterozryl compound for the treatment of cancer
Pierre Fabre Medicament 2315601*
- Methods for dosing an actriib antagonist and monitoring of treated patients
Acceleron Pharma 2315602*
- Polysaccharide-protein conjugates reversibly coupled via immune bonds
Therapure Biopharma 2315603*
- Dicarba-analogues of actreotide
Advanced Accelerator Applications 2315604*
- Cholesterol sulphate containing compsn as a haemostatic
Dr Suwelack Skin & Health Care 2315605*
- Formulations for a two-phase management of wound healing and dressings incorporating such formulations
BK Pharma Systems 2315606*
- Pyrimidul sulphonamide derivative and its use for the treatment of chemokine mediated diseases
AstraZeneca 2315754*
- Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols
Boehringer Ingelheim International 2315755*
- 1,2,5-oxadiazoles as inhibitors of indoleamine-2,3-dioxygenase
Incyte Corp 2315756*
- Production of hydroxymethylfurfural
Agency for Science, Technology and Research, Singapore 2315757*
- Isolongifolanyl-derivatives suitable as odorants
Givaudan 2315758*
- Method for storing and transporting cyclic diesters
Uhde Inventa-Fischer 2315759*
- Pharmaceutical compounds
Sentinal Oncology 2315761*
- Fluoro-substituted 3,4-diaryl-4,5-dihydro-1H-pyrazole-1-carboxamidine derivatives having CB1-antagonistic activity
Abbott Healthcare Products 2315762*
- Benzimidazoles and related analogues as sirtuin modulators
Sirtis Pharmaceuticals 2315763*
- Crystalline form of sunitinib and process for its preparation
Generics (UK) 2315764*
- Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl) butane-1,2,3,4-tetraol and methods of their use
Lexicon Pharmaceuticals 2315765*
- Octahydroquinolizines for antidiabetic treatment
55pharma Drug Discovery & Development 2315766*
- Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
Sanofi-Aventis 2315767*
- Thieno-pyridine derivatives as MEK inhibitors
UCB Pharma 2315768*
- Brassinosteroid regulated kinases (BRKS) that mediate brassinosteroid signal transduction and uses thereof
Carnegie Institute of Washington 2315770*
- Glycopeptide constructs and uses thereof
Sloan Kettering Institute for Cancer Research 2315771*
- Novel compsns and methods
GlaxoSmithKline Biologicals 2315773*
- Angiopoietin derived peptides
Compugen 2315775*
- T-cell receptors and related materials and methods of use
The United States of America, as represented by the Secretary, Department of Health and Human Services 2315776*
- Therapeutic use of specific ligand in MSRV associated diseases
Geneuro 2315777*
- Compsns monovalent for CD28 binding and methods of use
Domantis 2315778*
- Compsns comprising antibodies to LINGO or fragments thereof
Biogen Idec 2315779*
- Compsns and methods of use for therapeutic antibodies
Novartis 2315780*